Evidence map›Paper›PMID 39454050›Full record

Trial reportJAMA2024

Early, Individualized Recommendations for Hospitalized Patients With Acute Kidney Injury: A Randomized Clinical Trial.

Abinet M Aklilu, Steven Menez, Megan L Baker, Dannielle Brown, Katie K Dircksen, Kisha A Dunkley, Simon Correa Gaviria, Salia Farrokh, Sophia C Faulkner, Charles Jones and 18 more

Registry-linked trialAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in JAMA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04040296 (Personalized Recommendations for Acute Kidney Injury), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04040296 nacompletednot on this map

Personalized Recommendations for Acute Kidney Injury (AKI) Care Using a Kidney Action Team: A Randomized Trial

TypeinterventionalSponsorYale UniversityRan2021 to 2024Enrolled4,003ConditionsAcute Kidney InjuryArmsKidney Action Team Recommendations
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Age-Specific Prognostic Models for Sepsis-Associated Acute Kidney Injury: A Multicenter Cohort Study.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Abinet M AkliluClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Steven MenezDivision of Nephrology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Megan L BakerSection of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Dannielle BrownDepartment of Pharmacy, Johns Hopkins Hospital, Baltimore, Maryland.
Katie K DircksenDepartment of Pharmacy, Johns Hopkins Hospital, Baltimore, Maryland.
Kisha A DunkleyDepartment of Pharmacy, Johns Hopkins Hospital, Baltimore, Maryland.
Simon Correa GaviriaDivision of Nephrology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Salia FarrokhDepartment of Pharmacy, Johns Hopkins Hospital, Baltimore, Maryland.
Sophia C FaulknerClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Charles JonesDepartment of Pharmacy, Yale New Haven Hospital, New Haven, Connecticut.
Bashar A KadhimClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Dustin LeDivision of Nephrology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
Fan LiClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Amrita MakhijaniClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Melissa MartinClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Dennis G MoledinaClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Claudia Coronel-MorenoClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Kyle D O'ConnorClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Kyra SheltonClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Kristina ShvetsDepartment of Pharmacy, Yale New Haven Hospital, New Haven, Connecticut.
Nityasree SrialluriDivision of Nephrology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Jia Wei TanSection of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Jeffrey M TestaniClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Celia P Corona-VillalobosDivision of Nephrology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Yu YamamotoClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
Chirag R ParikhDivision of Nephrology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
F Perry WilsonClinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
KAT-AKI Team

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
POSTDOCTORAL TRAINING IN MEDICAL INFORMATION SCIENCEST15LM007033 · NLM · STANFORD UNIVERSITY · PI SYLVIA KATINA PLEVRITIS · 1985 to 2026
$25.5M
Novel Kidney Injury Tools in Deceased Organ Donation to Predict Graft OutcomesR01DK093770 · NIDDK · YALE UNIVERSITY · PI Chirag R Parikh · 2012 to 2026
$9.5M
Resource Development CoreU54DK137331 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI JOSEF CORESH · 2023 to 2026
$4.3M
Post-Discharge Nephrology Follow-up for Improved OutcomesU01DK129984 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Chirag R Parikh · 2021 to 2026
$4.2M
AKI Matched Phenotype Linked Evaluation with Tissue (AMPLE-Tissue)U01DK114866 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Chirag R Parikh · 2022 to 2026
$2.6M
Personalized Recommendations for Acute Kidney Injury (AKI) Care Using a Kidney Action Team: A Randomized TrialR01HS027626 · AHRQ · YALE UNIVERSITY · PI WILSON, FRANCIS PERRY · 2021 to 2025
$1.9M
Epidemiologic and Translational Investigation of Long-Term Kidney Outcomes After COVID-19K23DK128538 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MENEZ, STEVEN · 2021 to 2025
$990k
AHRQ HHS R01 HS027626NCATS NIH HHS UL1 TR001863NIDDK NIH HHS K23 DK128538NIDDK NIH HHS R01 DK093770NIDDK NIH HHS U01 DK114866NIDDK NIH HHS U01 DK129984NIDDK NIH HHS U54 DK137331NLM NIH HHS T15 LM007033
6 · The paper itself

Abstract

Importance: Acute kidney injury (AKI) is a common complication during hospitalization and is associated with adverse outcomes. Objective: To evaluate whether diagnostic and therapeutic recommendations sent by a kidney action team through the electronic health record improve outcomes among patients hospitalized with AKI compared with usual care. Design, Setting, and Participants: Randomized clinical trial conducted at 7 hospitals in 2 health systems: in New Haven, Bridgeport, New London, and Waterbury, Connecticut, and Westerly, Rhode Island; and in Baltimore, Maryland. Hospitalized patients with AKI were randomized between October 29, 2021, and February 8, 2024. Final follow-up occurred February 22, 2024. Intervention: An alert about AKI was sent to the kidney action team, consisting of a study physician and study pharmacist, which sent personalized recommendations through the electronic health record in 5 major categories (diagnostic testing, volume, potassium, acid base, and medications) within 1 hour of AKI detection. The note was immediately visible to anyone with access to the electronic health record. Randomization to the intervention or usual care occurred after the recommendations were generated, but the note was only delivered to clinicians of patients randomized to the intervention group. Main Outcomes and Measures: The primary outcome was a composite outcome consisting of AKI progression to a higher stage of AKI, dialysis, or mortality occurring while the patient remained hospitalized and within 14 days from randomization. Results: Of the 4003 patients randomized (median age, 72 years [IQR, 61-81 years), 1874 (47%) were female and 931 (23%) were Black patients. The kidney action team made 14 539 recommendations, with a median of 3 (IQR, 2-5) per patient. The primary outcome occurred in 19.8% of the intervention group and in 18.4% in the usual care group (difference, 1.4%, 95% CI, -1.1% to 3.8,% P = .28). Of 6 secondary outcomes, only 1 secondary outcome, rates of recommendation implementation, significantly differed between the 2 groups: 2459 of 7270 recommendations (33.8%) were implemented in the intervention group and 1766 of 7269 undelivered recommendations (24.3%) were implemented in the usual care group within 24 hours (difference, 9.5%; 95% CI, 8.1% to 11.0%). Conclusions and Relevance: Among patients hospitalized with AKI, recommendations from a kidney action team did not significantly reduce the composite outcome of worsening AKI stage, dialysis, or mortality, despite a higher rate of recommendation implementation in the intervention group than in the usual care group. Trial Registration: ClinicalTrials.gov Identifier: NCT04040296.

Indexed as

Acute Kidney InjuryElectronic Health RecordsHospitalizationPatient Care TeamAgedAged, 80 and overDisease ProgressionFemaleHospital MortalityHumansMaleMiddle AgedPotassiumTreatment OutcomePotassium

Identifiers

PMID39454050
PMCPMC11669049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.